SnwnIgG >6723@ 15 ml Stop Solution (red cap)

ELISA Test for the Detection of IgG Antibodies 

2
Sulphuric acid, ready for use
Adhesive Strips
0.5 mol/l

to Toxoplasma Gondii in Human Serum Preservatives: Total concentration < 0.1%

Package Size
Safety Notes
>5()@ 51209 96 Tests Complete Test Kit
Do not swallow the reagents. Avoid contact with eyes, skin and mucous
>,9'@ membranes. All patient specimens and controls should be handled as
potentially infectious. The controls have been checked on donor level for
Intended Use HCV and HIV-1/2 antibodies and HBsAg and found negative. Wear
The TOXO IgG ELISA is intended for the detection of Immunoglobulin G protective clothing and disposable gloves according to Good Laboratory
(IgG) class antibodies to 7R[RSODVPDJRQGLL in human serum. Practices.
Toxoplasma infects nearly all mammalians and birds. It is the most widely All materials contaminated with patient specimens or controls should be
distributed of all intracellular parasites. Humans become infected through inactivated by validated procedures (autoclaving or chemical treatment) in
contamination with feces or uncooked meat, or through direct accordance with applicable regulations.
inocculation via blood transfusions or congenital transmission.
>6723@ irritates eyes, skin and mucous membranes. Upon contact, rinse
Pregnant women who acquire toxoplasmosis during the first trimester thoroughly with copious amounts of water and consult a doctor.
have a 25% risk of fetal transmission resulting in spontaneous abortions,
stillborns, or severe disease. Sixty five percent of infants born to women Stability
infected during the third trimester have subclinical infection with The reagents are stable up to the stated expiry dates on the individual
ultimately 85% developing chorioretinitis or neurological sequelae. labels when stored at 2...8°C.
After opening reagents have to be stored at 2...8°C and used within 60
Principle- Classic EIA -
days (see also "Note").
The HUMAN TOXO IgG ELISA is based on the classical ELISA technique. The
microtiter strip wells as a solid are coated with 7R[RSODVPD antigens >0,&@(Code: TOX G)
(TOXO-Ag) prepared from sonicated whole 7R[RSODVPD JRQGLL parasites
 sealed in an aluminium bag with a desiccant.
(Tachyzoites). In the first incubation step corresponding specific antibodies
(TOXO-IgG-Ab) present in patient specimens or controls bind to the  must be at room temperature before opening,
antigens at the solid phase. At the end of the incubation unbound  unused: return with the desiccant to the zip-lock bag and store in this
components are washed out. For the second incubation step anti-IgG way at 2...8°C.
conjugate (anti-human IgG antibodies, peroxidase conjugated) is added
Do not touch the upper rim or the bottom of the wells with fingers.
which binds specifically to IgG class antibodies resulting in the formation
of typical immunocomplexes. After a second washing step to remove
Reagent Preparation
excess conjugate, TMB/Substrate is added (Step 3). A blue colour develops
Bring all reagents to room temperature (15...25°C) before use.
changing to yellow after stopping the reaction. The intensity of the colour
is directly proportional to the TOXO-IgG-Ab concentration in the specimen. Reagents not in use should always be stored at 2...8°C.
The absorbance of controls and specimen is determined by using ELISA
Notes
microplate readers or automated ELISA systems (like HUMAN´s
The general purpose reagents >',/*@ 5121, >:6@ 5102, >68%@ 5103,
HUMAREADER or ELISYS line). Results for patient samples are obtained
>6723@ 5104 are interchangeable between different lots and kits. For IgG
either by comparison with a cut-off control or in IU/ml by quantitative
tests use only IgG dilution buffer >',/*@ 5121.
estimation using a calibration curve constructed with the help of the cut-
off and 3 positive controls. All other reagents are specific for the individual package lot and must not
be interchanged with other lots. No reagents of other manufacturers
Reagents and Contents should be used along with reagents of this kit.
>0,&@ 12 Microtiter Strips (in 1 strip holder)
(Code TOX G) Working Wash Solution>:$6+@
8-well snap-off strips  dilute >:6@ 5102 1+20 with fresh deionised water, e.g. 50 ml >:6@ 5102
coated with sonicated 7R[RSODVPDJRQGLL antigen + 1000 ml = 1050 ml.
>1&@ 2.5 ml TOXO IgG Negative Control(green cap)  Stability: up to 60 days at 15...25°C.
ready for use, human
>&&@ 2.5 ml TOXO IgG Cut-Cff Control (white cap) Specimen
ready for use, human 5.0 IU/ml Serum
>3&/@ 2.5 ml TOXO IgG Positive Control Low(red cap) Do not use highly lipemic or hemolysed specimens.
ready for use, human 30 IU/ml
Specimens may be stored for 7 days at 2...8°C or longer at -20°C. Freeze
>3&0@ 2.5 ml TOXO IgG Positive Control Medium(red cap)
and thaw once only. Thawed specimen must be homogenised. Eliminate
ready for use, human 100 IU/ml particulate matter by centrifugation or filtration.
>3&+@ 2.5 ml TOXO IgG Positive Control High(red cap)
ready for use, human 200 IU/ml Procedure
>&&@, >3&/@ >3&0@ , >3&+@:Calibrated against the 2nd Follow the procedure exactly as described.
International Standard Preparation (WHO anti-
Toxoplasma serum). 3URFHGXUDO1RWHV
>',/*@ 100 ml Dilution Buffer IgG (white cap) P1: Do not mix caps of vials (risk of contamination). Do not use reagents
 Ready for use, coloured green pH 6.5 r 0.2 after their expiration date.
Phosphate buffer 10 mmol/l P2: Do not use reagents that could be contaminated or look or smell
NaCl 8 g/l different than usual.
Albumin 10 g/l P3: Record specimens and controls carefully on the spread sheet supplied
>&21@ 12 ml Anti-IgG Conjugate (white cap) with the kit.
Ready for use, coloured red
P4: >0,&@ - select the required number of Microtiter Strips.
Anti-human IgG (rabbit), peroxidase-conjugated
>:6@ 50 ml Washing Solution (white cap) P5: Run duplicates for controls. Pipette controls and specimen on the
 Concentrate for about 1000 ml pH 7.2 r 0.2 bottom in the microwells.
Tris buffer 10 mmol/l P6: Always add reagents in the same order and timing to minimise
NaCl 8 g/l reaction time differences between wells. This is important for
>68%@ 13 ml Substrate Reagent(black cap) reproducible results. Pipetting of specimens should not exceed 5 minutes.
 ready for use, colourless to bluish pH 3.7 ± 0.2 Otherwise pipette the controls in the indicated positions at half way time
3,3', 5,5'-tetramethylbenzidin (TMB) 1.2 mmol/l of the series. If more than 1 plate is used, repeat the controls for each
Hydrogen peroxide 3 mmol/l plate.
P7: Avoid/remove air bubbles prior to incubations and reading of Interpretation of Results
absorbance. A450 (patient) t MCC + 15%: anti-TOXO-IgG-Ab-positive
P8: >68%@ – incubate in the dark. >68%@ initiates a kinetic reaction, which is A450 (patient)  MCC -15%: anti-TOXO-IgG-Ab-negative
terminated by >6723@.
Due to physiological and analytical variations patient results lying 15%
:DVK3URFHGXUH
above or below the calculated cut-off are equivocal. It is recommended to
The wash procedure is critical. Insufficient washing will result in poor measure these samples in parallel with a fresh sample taken 7 to 14 days
precision or falsely high absorbance. later, each in duplicate. The trend between the specific antibody levels
W1: Remove Adhesive Strips, aspirate off the contents into 5% sodium should be used for interpretation, also taking into consideration the
hypochlorite solution and add >:$6+@ to each well, aspirate off after 30 patient history and additional investigations. Repeatedly reactive or
sec. soak time and repeat washing 3 resp. 4 times. equivocal samples may be subjected to a confirmatory test.
W2: In case of automatic washers fill and prime with >:$6+@.
Subsequently wash strips 4 resp. 5 times. Ensure the washer fills all wells Quantitative Estimation of Toxoplasma IgG in Patient Samples
completely and aspirates off efficiently after 30 sec. (remaining liquid: < For a quantitative estimate of Toxoplasma IgG antibody levels of positive
15 μl). specimens in IU/ml, the MCC and the 3 MPCs (low, medium, high)
W3: After washing, remove remaining liquid by tapping the plate upside (ordinate) are plotted in a graph versus their corresponding 7 JRQGLL IgG
down on tissue paper. concentrations of 5, 30, 100, and 200 IU/ml (abscissa).
The estimate of levels in patient sera are read off the graph using their
3LSHWWLQJ6FKHPH individual A450.
Reagents and specimens should be at room temperature before use. Patient sera with A450 greater than the >3&+@ (200 IU/ml) should be
further diluted with dilution buffer IgG, and reassayed before estimating
Sample Preparation:
antibody levels.
Dilute the patient’s sera 1+100 with >',/*@5121, e.g. 10 μl serum + 1
ml >',/*@ 5121, mix thoroughly. The clinical significance of changes in 7R[RSODVPD JRQGLL specific IgG
Diluted samples can be stored up to 48 h at 2...8°C before testing.
levels must be interpreted with care.
Controls are ready for use.
6WHS :HOO>ðO@ Performance Characteristics
A1 B1/C1 D1/C2 D2... Typical performance data can be found in the Verification Report,
Blank >1&@ >3&@ Sample accessible via
>1&@ in duplicate -- 100 -- -- www.human.de/data/gb/vr/el-toxog.pdf or
>&&@ in duplicate, D1/E1 -- -- 100 --
www.human-de.com/data/gb/vr/el-toxog.pdf
>3&/@ in duplicate, F1/G1 -- -- 100 --
>3&0@ in duplicate, H1/A2 -- -- 100 -- Note
>3&+@ in duplicate, B2/C2 -- -- 100 -- The components of the kit are stable until the expiry date even after
Diluted samples -- -- -- 100 opening. However, a potential contamination is directly related to the
>0,&@cover with Adhesive Strips number of samplings. The 60 days limit after first use is set for safety
reasons.
Incubate 30 min. at 17...25°C
Wash 4 times as described (see W1 - W3) The handling should always be in compliance with common GLP
requirements (*)! The validation criteria must be met!
>:$6+@ 350 350 350 350
(*This includes: Proper caps being replaced on the vials and firmly tightened / Remove only
6WHS
reagents required for a run from stock solutions if they could come into contact with other
>&21@ -- 100 100 100 contaminating solutions like patient specimens etc. / Stock solutions always returned to
>0,&@cover with Adhesive Strips 2...8°C when not in use.)
Incubate 30 min. at 17...25°C
Wash 5 times as described (see W1 - W3) Literature
1. Engvall, E., Perlmann, P., Immunochemistry 8, 871-874 (1971)
>:$6+@ 350 350 350 350
6WHS 2. Engvall, E., Perlmann, P., J. Immunol. 109, 129-135 (1972)

>68%@ 5103 100 100 100 100 3. Remington, J.S., Klein, J.O., Infectious diseases of the fetus and newborn
infant. Sanders, Philadelphia, London, Toronto (1976)
Incubate 15 min. at 17...25°C (see P8)
100 100 100 100 4. Bidwell, D.E. HWDO., J. Infect. Dis. 136, Supplement 274-278 (1977)
>6723@ 5104
Mix carefully 5. Volk, W.A. Essentials of Medical Microbiology. Second ed., J.B. Lippincott
Zero the ELISA microtiter plate reader (HUMAREADER) using the Company, Philadelphia, New York, San Jose, Toronto, 728-279 (1982)
substrate blank in well A1.
Measure the absorbance at 450 nm as soon as possible or within 30
min.after terminating of the reaction, using a reference wavelength of EL-TOXOG INF 5120901 GB 05-2007-17 |
630-690 nm (if available). 0483

Calculation of Control Values and Cut-off

Mean absorbance values of >1&@(MNC) , of >&&@ (MCC) and of >3&/@, >3&0@,
>3&+@ (MPCL, MPCM, MPCH) are calculated according following example:

A450 (D1) + A450 (E1)

MCC = 
2

The test run may be considered valid provided that the following criteria
are met:
1. Substrate blank in well A1 < 0.150
2. MNC d MCC
3. MPCM t 0.750
4. MPCM : MNC t 5

Human Gesellschaft für Biochemica und Diagnostica mbH

Max-Planck-Ring 21 · 65205 Wiesbaden · Germany
Telefon +49 6122-9988-0 · Telefax +49 6122-9988-100 · e-Mail human@human.de